• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Bone Biologics Corp.

Bone Biologics prices $5.1M offering

October 7, 2022 By Sean Whooley

Bone Biologics (Nasdaq:BBLG) announced today that it priced an underwritten public offering worth $51. million. The offering includes nearly 3.8 million units of securities. Each unit costs $1.35. The gross proceeds total $5.1 million before deducting underwriting discounts and commissions, plus other offering expenses. Each unit features one share of common stock. They also include […]

Filed Under: Business/Financial News, Funding Roundup, Orthopedics, Regenerative Medicine, Wall Street Beat Tagged With: Bone Biologics Corp.

Bone Biologics raises another $6m

July 23, 2018 By Brad Perriello

Bone Biologics (OTC:BBLG) said today that it raised another $5.9 million for the orthobiologics it makes for spinal fusion procedures. The round includes $3.9 million in equity and a $2 million credit facility, the Burlington, Mass.-based company said. Bone Biologics said it plans to use the proceeds for working capital, protein development and regulatory and clinical […]

Filed Under: Funding Roundup, Orthopedics, Regenerative Medicine, Wall Street Beat Tagged With: Bone Biologics Corp.

Bone Biologics closes $5.8m round

April 20, 2016 By Fink Densford

Regenerative orthobiologic company Bone Biologics said it recently closed a $5.75 million round joined by the Musculoskeletal Transplant Foundation, Orthofix (NSDQ:OFIX) and Hankey Capital to support development of its bone graft substitute. Boston-based Bone Biologics is developing Nell-1, a bone growth factor designed to be an alternative to other bone growth factors used in surgical procedures such […]

Filed Under: Business/Financial News, Regenerative Medicine, Spine Tagged With: Bone Biologics Corp.

NeuSpera Medical lands ex-Cyberonics R&D SVP Morris for CEO | Personnel Moves

August 18, 2015 By Brad Perriello

NeuSpera Medical said it snagged the former R&D senior vice president at Cyberonics, Milton Morris, for its corner office as it gears up to raise a Series A round for its neuromodulation technology. NeuSpera, formerly known as Vivonda Medical, is developing injectable neuromodulation devices, so called “electroceuticals,” using licensed mid-field powering technology. The Santa Clara, […]

Filed Under: Neuromodulation/Neurostimulation Tagged With: Bone Biologics Corp., Check-Cap, Nephros, NeuSpera Medical, Nuvasive, Personnel Moves

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy